Dr. Matthew Emery Hardee, MD, PhD

Dr. Hardee practices at The Breast Center at CARTI in Little Rock, Arkansas.

Dr. Hardee's NPI, 1487896973, was assigned on March 30, 2009. Dr. Hardee graduated from Duke University School of Medicine in 2007. Dr. Hardee holds Arkansas license E-7372.

Dr. Hardee's primary practice is The Breast Center at CARTI, at 8901 Carti Way, Little Rock, AR 72205. The practice phone is (501) 906-3003.

Dr. Hardee's primary practice is The Breast Center at CARTI in Little Rock, Arkansas. The medical group on file is CARTI. Dmand AI also links Dr. Hardee to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Hardee's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hardee practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Hardee's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Hardee is licensed in Arkansas.

CMS data shows 4,750 Medicare services from Dr. Hardee across 20 procedure codes in 2024, for 402 Medicare patients. Medicare paid $437,203 for them. Every service was in an office.

CMS counts 402 Medicare patients who saw Dr. Hardee in 2024. The largest group is 65 to 74, with 195 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hardee's median patient age at 71, with 49% women.

In 2024, Dr. Hardee wrote 175 Medicare Part D claims for 86 patients. 96% of them were for generic drugs. CMS names the drug for 140 of them, across 4 drugs with 11 or more claims each, at $1,176 in total drug cost. In 2023, CMS named 93 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Hardee for performance year 2024, reported as part of a group. Dr. Hardee accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Hardee, published from 2011 to 2016. 2012 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Cell Hypoxia and Radiotherapy, Intensity-Modulated. Dr. Hardee's most frequent co-authors are Jose Penagaricano, MD, Ariel E. Marciscano, MD and Daniela Alessandra Ochoa, MD.

Dmand AI links Dr. Hardee to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 21 general payments to Dr. Hardee from 12 drug and device companies from 2016 to 2022. Travel and lodging make up the largest share, 77% of the total. Varian Medical Systems, Inc. paid the most, $975.

Dr. Hardee graduated from Duke University School of Medicine in 2007.